Pure Global
NCT06372262

Effect of 2000-meter Rowing Test on Parameters of Intestinal Integrity in Elite Rowers During Competitive Phase

Poznan University of Physical Education·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Endothelial Dysfunction
Drug/Device/Intervention
ergometer test
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Poznan University of Physical Education
Location
Poznań, Poland
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2022
End date
Jun 30, 2022
Enrollment
18 participants
Primary outcome

I-FABP (intestinal fatty acid binding protein)to measure epithelial wall injury,zonulin to measure tight junction leakage,LBP (lipopolysaccharide binding protein) to measure endotoxin,LPS (lipopolysaccharide) to measure endotoxin,Lactic acid to measure fatigue after the race

Summary

The study aimed to check the 2000m ergometer test on markers of gut permeability in the
 competitive phase of rowers. 18 members of the Polish rowing team took part in the study.

ICD-10 classifications
Other peripheral vascular diseasesAtherosclerosis of arteries of extremitiesOther specified peripheral vascular diseasesRenovascular hypertensionOther disorders of arteries and arterioles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06372262
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06372262 through Pure Global AI's free database. This phase not specified trial is sponsored by Poznan University of Physical Education and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.